BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT06287229-completion@plaintrial.com
DTSTAMP:20261110T225816Z
DTSTART;VALUE=DATE:20301231
SUMMARY:Phase Ib/II Study Assessing the Clinical Activity and Safety of Bre
 xucabtagene Autoleucel as a Consolidation in Patients With Relapsed/Refrac
 tory (R/R) and Newly Diagnosed B-cell Acute Lymphocytic Leukemia (ALL) Pos
 t Cytoreduction With Mini-HCVD-inotuzumab-blinatumomab/HCVAD-inotuzumab-bl
 inatumomab — estimated completion date
DESCRIPTION:Recruiting. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT06287229
URL:https://plaintrial.com/trial/NCT06287229
END:VEVENT
END:VCALENDAR